Multicenter trial of prolonged infusions of rocuronium bromide in critically ill patients: effects of multiple organ failure.

Autor: Circeo LE; Department of Anesthesia, Baystate Medical Center, Tufts University School of Medicine, Springfield, Mass 01199, USA., Reeves ST
Jazyk: angličtina
Zdroj: Southern medical journal [South Med J] 2001 Jan; Vol. 94 (1), pp. 36-42.
Abstrakt: Background: This study was done to determine the safety, efficacy, dosing requirements, and spontaneous recovery profiles of prolonged infusions of rocuronium bromide in the critically ill.
Methods: This multicenter, prospective, nonrandomized, open label trial enrolled 32 patients at two university-based medical centers. Patients who were determined to require neuromuscular blockade for at least 24 hours received a bolus of 0.6 mg/kg of rocuronium. After subsequent recovery of two responses (T2) to the TOF stimulation, an infusion of rocuronium was begun at 10 microg/kg/min and continued for 24 to 120 hours as required by the patients' clinical status.
Results: Patients were divided into multiple organ failure (MOF) and non-multiple organ failure (non-MOF) groups on enrollment. The mean infusion rates for the MOF and non-MOF groups were 0.2 and 0.5 mg/kg/hour, respectively.
Conclusion: The mean infusion rate of rocuronium that provides approximately 90% blockade is less for critically ill patients with MOF. Spontaneous recovery was prolonged in patients with MOF.
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje